Alnapharm
Alnapharm
Alnapharm

Alnovat and Psoriasis

Alnovat a new innovative topical cream to treat Psoriasis.

Psoriasis is a chronic, incurable dermatological disease with strong psychological strain. The prevalence of Psoriasis in western countries is about 2-3% of the population. About 1.7 million people in Germany are affected and worldwide more than 125 million people suffer from Psoriasis. The burden of patient is very high and they suffer from a significant restriction of their quality of life. Surveys have shown significant impairment of the quality of life that is similar to type 2 diabetes or chronic lung disease.

Most of the patients use topical and systemic therapies to treat the disease. Topical therapies remain the mainstay of treatment for mild Psoriasis. Also patients with serve Psoriasis often use topical therapies. The main groups of topical therapies are emollients, vitamin D and its analogues, e.g. the vitamin D derivate calcipotriol, topical corticosteroids, coal tar preparations, dithranol, and tazarotene. The current patient care leads to a low patient satisfaction with a poor adherence to therapy. About 20% of the patients with Psoriasis are low satisfied with their current therapies and about 50% tolerate their current therapies, but they are not very satisfied.

Reasons for this are:

  • Poor tolerance
  • Fear and lack of information
  • Adverse drug reactions
  • Poor efficacy and high complexity
  • Uncertainties in the application

Alnovat solves many of this problems.

Anovat differs from current available creams and ointments:

  • The cream contains pure natural ingredients
  • No time limit in application
  • Excellent nourishing properties

The performance based upon a unique formulation of different herbal oils and its efficacy is proven by international, randomized, double-blinded, controlled clinical trial at about more than 135 patients. The efficacy has been tested against a placebo and an international gold standard product. The clinical trial has been finished successfully and show a significant superiority over gold standard.

Alnovat treats Psoriasis very effective by reactivation of the natural barrier function and natural regeneration process of the skin. Psoriasis is an inflammatory skin condition. Inflammatory conditions entails the formation of free radicals. These free radicals are capable of destroying cells and cell compartments. The application of the cream leads to reduction of these free radicals, thus stimulating the healing processes of Psoriasis.

Patients

Here you find complex information about Alnovat®. Additionally we report on psoriasis treatment and success storiesmore

Congresses and Events

Here you find complex information about Alnovat®. Additionally we report on analysis, indication and preanalytics as book of reference for doctors.

Psoriasis

Psoriasis vulgaris (psoriasis) represents a frequent and almost always chronically progressing dermatological disease.

Application of Alnovat®

Alnovat cream is applied topically twice daily as a thin layer to the skin affected by psoriasis, allowing then absorption into the skin.